BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNMT1
,
T cell receptor signaling pathway
,
Breast Cancer
,
Embryo
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SHP-1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Spleen
Tonsil
Whole blood
Bone marrow
Lymph nodes
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the prog…
Multiple phosphorylation of the Cdc48/p97 cofactor protein Shp1/p47 occurs upon cell stress in buddi…
Regulation of autoimmune arthritis by the SHP-1 tyrosine phosphatase.
Cdc48/Shp1 participates in dissociation of protein complexes to regulate their activity.
SHP-1 ameliorates nonalcoholic steatohepatitis by inhibiting proinflammatory cytokine production.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Improving Wellbeing of SHP Personnel at UAB
Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)
RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line…
Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Local…
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Stud…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ